BlackRock, Inc.

Holdings History for Protagonist Therapeutics, Inc - Common Stock, $0.00001 par value (PTGX)

Symbol: PTGX on Nasdaq
Investment type: Equity / Common Stock, $0.00001 par value
Latest Disclosed Shares Owned: 8,575,669 shares
Security Ownership %: 14%

Shares, Excluding Options vs Price

Value, Excluding Options

BlackRock, Inc. ownership in Protagonist Therapeutics, Inc Common Stock, $0.00001 par value (PTGX)

17 Oct 2025 - BlackRock, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8,575,669 shares of Protagonist Therapeutics, Inc Common Stock, $0.00001 par value (PTGX). This represents 14% ownership of the company. In their previous filing dated 29 Apr 2025, BlackRock, Inc. had reported owning 9,084,682 shares, indicating a decrease of +5.6%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BlackRock, Inc.	14%	-6.7%	$569,681,692	8,575,669	-509,013	-5.6%	$66.43	13G/A	30 Sep 2025	17 Oct 2025, 18:24
BlackRock, Inc.	15%	-11%	$404,177,502	9,084,682	-799,935	-8.1%	$44.49	13G/A	31 Mar 2025	29 Apr 2025, 14:53
BlackRock, Inc.	17%		$439,766,610	9,884,617			$44.49	13G/A	31 Dec 2024	05 Feb 2025, 13:23

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	+0%	$848,595,367	9,715,999	+311,767	+3.3%	$87.34	Q4 2025
30 Sep 2025	0.01%	-0%	$624,723,149	9,404,232	-226,109	-2.3%	$66.43	Q3 2025
30 Jun 2025	0.01%	-0%	$532,268,963	9,630,341	-106,426	-1.1%	$55.27	Q2 2025
31 Mar 2025	0.01%	-0%	$470,870,063	9,736,767	-147,850	-1.5%	$48.36	Q1 2025
31 Dec 2024	0.01%	-0%	$381,546,216	9,884,617	-339,678	-3.3%	$38.60	Q4 2024
30 Sep 2024	0.01%	0%	$460,093,275	10,224,295	0		$45.00	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.